Michael Gelband’s MiMedx Group MDXG Stock Holding History

Michael Gelband’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$795K	Buy	+206,439	New	+$753K	0.01%	1127
2026 Q1	–	Sell	-36,645	Closed	-$248K	–	1880
2025 Q4	$248K	Sell	36,645 -46,323	-56%	-$325K	﹤0.01%	1353
2025 Q3	$579K	Buy	82,968 +71,233	+607%	+$495K	0.01%	1136
2025 Q2	$72K	Sell	11,735 -123,038	-91%	-$818K	﹤0.01%	1367
2025 Q1	$1.02M	Buy	+134,773	New	+$1.13M	0.01%	916
2024 Q3	–	Sell	-176,351	Closed	-$1.22M	–	1896
2024 Q2	$1.22M	Buy	+176,351	New	+$1.24M	0.01%	948
2023 Q3	–	Sell	-92,208	Closed	-$609K	–	1958
2023 Q2	$609K	Buy	+92,208	New	+$470K	0.01%	1285
2022 Q1	–	Sell	-32,427	Closed	-$196K	–	2481
2021 Q4	$196K	Buy	32,427 +502	+2%	+$3.49K	﹤0.01%	1838
2021 Q3	$193K	Buy	+31,925	New	+$360K	﹤0.01%	1794
2021 Q2	–	Sell	-430,142	Closed	-$4.43M	–	2625
2021 Q1	$4.43M	Buy	430,142 +71,725	+20%	+$693K	0.06%	319
2020 Q4	$3.25M	Buy	+358,417	New	+$2.58M	0.03%	374

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Michael Gelband's MDXG Position: Q2 2026 in Review

Michael Gelband opened a new position in MiMedx Group (MDXG) in Q2 2026: 206,439 shares worth $795K. The stake represents 0.01% of the portfolio and ranks #1127 among its holdings. This is a return to the name: Michael Gelband previously reported a position in MDXG as recently as Q4 2025.

Michael Gelband first reported a position in MDXG in Q4 2020 and has held it in 11 quarters since. The position peaked at $4.43M in Q1 2021. 225 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Michael Gelband held 206,439 shares of MiMedx Group worth $795K as of Q2 2026.
MiMedx Group was a new Michael Gelband position in Q2 2026.
MiMedx Group made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1127 holding.
Michael Gelband first reported a position in MiMedx Group in Q4 2020 and has held it in 11 quarters since.
Michael Gelband's MiMedx Group position peaked at $4.43M in Q1 2021.
225 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.